Press release
New Study Reveals Chemotherapy Induced Neutropenia (CIN) - Market Insights, Epidemiology Forecast-2023
DelveInsight’s “Chemotherapy Induced Neutropenia (CIN) – Market Insights, Epidemiology and Market Forecast-2023” Report provides an overview of the disease and global market trends of the Chemotherapy Induced Neutropenia for the seven major markets i.e., United States, Europe (France, Germany, Italy, Spain, UK) and Japan, as well as rest of Europe (RoE) and rest of the world (RoW). The Report covers the therapeutics market revenue, treatment practice and Chemotherapy Induced Neutropenia (CIN) forecasted market share from 2017 to 2023 segmented by seven major markets. In addition, the report provides the historical and forecasted data of incident cases at risk of Chemotherapy Induced Neutropenia (CIN) in 10 Cancer indications till 2023.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1045347
The report covers the number of patients for 10 cancer indications (i.e. Breast Cancer, Leukemia, Prostate Cancer, Lung Cancer, Cervical Cancer, Pancreatic Cancer, Colorectal Cancer, Ovarian Cancer, Hodgkin’s disease and Non-Hodgkin Lymphoma), who are at risk of developing CIN as an adverse event of the chemotherapies of respective cancers. Neupogen (Filgrastim), developed and marketed by Amgen is the first G-CSF approved for chemotherapy-induced neutropenia (CIN) in 1991. Its PEGylated formulation, Neulasta was later approved in 2002. Filgrastim i.e., Neupogen and PEGylated filgrastim (Neulasta) contribute
to majority of the market size, of CIN. However, New Chemical Entities are expected to launch in the near future. According to DelveInsight, the Global Market size of CIN in 2016 was USD 3.67 Billion.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.
Table of Content
Report Introduction
Chemotherapy Induced Neutropenia (CIN) Market Overview at a Glance
Global Market Size of CIN in 2016
Global Market Size of CIN in 2023
Chemotherapy Induced Neutropenia (CIN)
Overview
Causes of Neutropenia
Common cycle of chemotherapy-related neutropenia
Signs and symptoms
Risk Factors
Severity and Grades of Neutropenia
Pathophysiology/ Mechanisms of action
Diagnosis
Epidemiology and Patient Population
Assumptions and Caveats
United States
Incident Cases of ten major Cancer indications in United States
Incident Cases of Chemotherapy Induced Neutropenia based on ten major Cancer
indications in United States
Ten major cancer patients at low risk of CIN in United States
Ten major cancer patients at intermediate to high risk of CIN in United States
Europe
Germany
Incident Cases of ten major Cancer indications in Germany
Incident Cases of Chemotherapy Induced Neutropenia based on ten major Cancer indications in Germany
Ten major cancer patients at low risk of CIN in Germany
Ten major cancer patients at intermediate to high risk of CIN in Germany
United Kingdom
Incident Cases of ten major Cancer indications in United Kingdom
Incident Cases of Chemotherapy Induced Neutropenia based on ten major Cancer
indications in United Kingdom
Ten major cancer patients at low risk of CIN in United Kingdom
Ten major cancer patients at intermediate to high risk of CIN in United Kingdom
Italy
Incident Cases of ten major Cancer indications in Italy
Incident Cases of Chemotherapy Induced Neutropenia based on ten major Cancer
indications in Italy
Ten major cancer patients at low risk of CIN in Italy
Ten major cancer patients at intermediate to high risk of CIN in Italy
Spain
Incident Cases of ten major Cancer indications in Spain
Incident Cases of Chemotherapy Induced Neutropenia based on ten major Cancer
indications in Spain
Ten major cancer patients at low risk of CIN in Spain
Ten major cancer patients at intermediate to high risk of CIN in Spain
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1045347
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release New Study Reveals Chemotherapy Induced Neutropenia (CIN) - Market Insights, Epidemiology Forecast-2023 here
News-ID: 491336 • Views: …
More Releases from Chemotherapy Induced Neutropenia
Latest Report Details Of Chemotherapy Induced Neutropenia - Pipeline Review, H2 …
"The Report Chemotherapy Induced Neutropenia - Pipeline Review, H2 2016 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
Global Markets Directs, Chemotherapy Induced Neutropenia - Pipeline Review, H2 2016, provides an overview of the Chemotherapy Induced Neutropenia pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Chemotherapy Induced Neutropenia, complete with analysis by stage of development, drug target, mechanism…
More Releases for CIN
CIN and HR-HPV Treatment Market Early Intervention, Lasting Impact: The Role of …
CIN and HR-HPV Treatment Market to reach over USD 20.08 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global CIN and HR-HPV Treatment Market Size, Share & Trends Analysis Report By Disease Type (Cervical Intraepithelial Neoplasia 1, Cervical Intraepithelial Neoplasia 2, and Cervical Intraepithelial Neoplasia 3), Strain Type (HPV 16, HPV 18, and Others),…
Powder Coatings Market to Witness Huge Growth by 2030: CIN, Plastcoat, PPG Indus …
The " Powder Coatings - Market Development Scenario " Study has been added to HTF MI database. The study covers an in-depth overview, description of the Product, and Industry Scope and elaborates market outlook and growth status to 2029. At present, the market is developing its presence following the current economic slowdown and its Impact. Some of the key players considered in the study are AkzoNobel Powder Coatings, CIN, Axalta…
Aerosol Paints Market 2022 Boosting the Growth Worldwide | Markal, CIN, Dupli Co …
This Aerosol Paints market is Statistical surveying reports by Worldwide Market Reports give important understanding to business tacticians. This Aerosol Paints market study gives extensive information that widen the arrangement, degree, and use of this report. A particular investigation of the cutthroat scene of the Global Aerosol Paints Market has given bits of knowledge into the organization profile, monetary position, late turns of events, consolidations and acquisitions, and henceforth SWOT…
Cervical Intraepithelial Neoplasia (CIN) H1 2017 – Pharmaceutical Pipeline Gui …
Market Research Hub (MRH) has added a new report titled “Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H1 2017”, to its vast database. Cervical intraepithelial neoplasia (CIN), also known as cervical dysplasia is characterized by abnormal appearance of cells on the surface of the cervix. Cervical dysplasia usually occurs in women aging twenty five to thirty five. Most cases of cervical dysplasia are caused by human papilloma virus (HPV). Factors…
Chemotherapy Induced Neutropenia (CIN) – Market Insights, Epidemiology and Mar …
DelveInsight’s Chemotherapy Induced Neutropenia (CIN) https://www.delveinsight.com/chemotherapy-induced-neutropenia-nbsp-market-insights-epidemiology-and-market-forecast-2023-5254-p.php – Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Chemotherapy Induced Neutropenia (CIN) for the seven major markets i.e., United States, Europe (France, Germany, Italy, Spain, UK) and Japan in ten major indications at risk of CIN i.e., Breast Cancer, Leukemia, Prostate Cancer, Lung Cancer, Cervical Cancer, Pancreatic Cancer, Colorectal Cancer, Ovarian…
Chemotherapy Induced Neutropenia (CIN) Market Insights and Market Forecast Repor …
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Chemotherapy Induced Neutropenia (CIN) - Market Insights, Epidemiology and Market Forecast-2023” to its report offerings. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.
Request for Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1045347
DelveInsight’s “Chemotherapy Induced Neutropenia (CIN) – Market Insights, Epidemiology and Market…
